Recognizing National Glaucoma Awareness Month
January was National Glaucoma Awareness Month and provided us an opportunity to spread the word and honor the millions of patients around the world who are impacted by this debilitating disease. Glaucoma refers to a group of eye diseases that can cause vision loss or blindness due to damage of the optic nerve. It is one of the leading causes of irreversible blindness in the United States. High intraocular pressure (IOP) is a common risk factor for glaucoma, which over time causes stress on the optic nerve and can lead to gradual vision loss. While there currently is no available cure, the condition can be treated and ...
Source: The Catalyst - February 1, 2023 Category: Pharmaceuticals Authors: Matthew Norawong Tags: Medicines in Development Patients R & D Focus Source Type: news

Nigeria: Danger! Bitter Kola Eye Drops Won't Cure Glaucoma, Myopia and Other Eye Problems - See Doctor Instead
[Africa Check] IN SHORT: Our eyes are sensitive and easily damaged, which could lead to blindness. Don't put anything in your eyes that hasn't been approved by a qualified health professional. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 31, 2023 Category: African Health Source Type: news

Mayo Clinic Minute: Protecting your eyesight from glaucoma
Glaucoma is one of the world ’s leading causes of blindness, according to the Centers for Disease Control and Prevention. January is Glaucoma Awareness Month. Half of people with glaucoma don ’t even know they have it. If you’re over 60 or have a family history of glaucoma, your risk is higher. But there is a way to protect your vision. Dr. Dave Patel, a Mayo Clinic ophthalmologist, explains one of the most important things you can do to prevent glaucoma from stealing your sight. Watch: The Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 26, 2023 Category: Databases & Libraries Source Type: news

Lens subluxation after use of a percussion massage gun: a case report - Mu J, Fan W.
RATIONALE: To report the first case of lens dislocation and secondary acute angle-closure glaucoma (AACG) following use of a percussion massage gun (PMG) around the eye. PATIENT CONCERNS: A 69-year-old Chinese man had been using a PMG around his right ... (Source: SafetyLit)
Source: SafetyLit - January 13, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Consumer Health: Do you know the symptoms of glaucoma?
January is National Glaucoma Awareness Month, which makes this a good time to learn more about treating this group of eye conditions. About 3 million people in the U.S. have glaucoma, and it's the second-leading cause of blindness worldwide, according to the Centers for Disease Control and Prevention. Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high pressure in your eye. Elevated eye pressure is due to a buildup of… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 5, 2023 Category: Databases & Libraries Source Type: news

What Is Glaucoma, and How Can You Prevent It?
WEDNESDAY, Jan. 4, 2023 -- A comprehensive eye exam could be the key to determining if you have glaucoma, a silent thief of sight. Glaucoma is a group of eye diseases that affect the optic nerve, and the leading cause of preventable blindness,... (Source: - Daily MedNews)
Source: - Daily MedNews - January 4, 2023 Category: General Medicine Source Type: news

Mayo Clinic Q and A: Glaucoma -- the 'silent thief of sight'
DEAR MAYO CLINIC: During my recent eye exam, the eye doctor used a machine to blow a puff of air into each of my eyes. It felt like I was in a video game, but I was the target. It didn't hurt, but it did startle me. What does this test measure and how is it helpful in evaluating my vision? Is this something I need to have regularly repeated? ANSWER: Vision tests are always important to… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 4, 2023 Category: Databases & Libraries Source Type: news

FDA Approves Iyuzeh (latanoprost ophthalmic solution) for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension
Iyuzeh™ (latanoprost ophthalmic solution) 0.005% is the first and only preservative-free formulation of latanoprost, the most prescribed prostaglandin F2α analogue (PGA) in the United States LEXINGTON, Massachusetts– December... (Source: - New Drug Approvals)
Source: - New Drug Approvals - December 14, 2022 Category: Drugs & Pharmacology Source Type: news

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX ® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
NEW ORLEANS, December 12, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow-up of 64.5 months, and overall survival (OS) at a median follow-up of 73.6 months in newly diagnosed, transplant-ineligible (TIE) patients with multiple myeloma, regardless of patients’ age and across clinically important subgroups, as well as health...
Source: Johnson and Johnson - December 12, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma
TARRYTOWN, N.Y., Dec. 8, 2022 /PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment... (Source: - New Drug Applications)
Source: - New Drug Applications - December 8, 2022 Category: Drugs & Pharmacology Source Type: news

Prescribed anti-glaucoma medication consumption and road traffic crash - Lu L, Contrand B, Schweitzer C, Gadegbeku B, Delcourt C, Lagarde E.
BACKGROUND: Glaucoma is one of the leading causes of visual impairment worldwide. Influence of visual defects associated with this condition, as well as potential side effects of anti-glaucoma medications on driving may be a relevant traffic safety concern... (Source: SafetyLit)
Source: SafetyLit - December 5, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

South Africa: International Day of Persons With Disabilities - 'It Always Seems Impossible Until It's Done'
[UCT] Teenagers the world over will agree: entering your teen years is much like a rite of passage. It's a steppingstone to young adulthood and many 12-year-olds eagerly anticipate their 13th birthday. It was no different for Benedict Leteane. But, in 1999, a few months after his 13th birthday, congenital glaucoma claimed his eyesight and changed the trajectory of his life forever. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 2, 2022 Category: African Health Source Type: news

Mean Length of Preclinical Detectable Phase of Glaucoma & gt;10 Years
TUESDAY, Nov. 29, 2022 -- The mean length of the preclinical detectable phase (PCDP) of open-angle glaucoma is estimated to be over 10 years, according to a study published online Nov. 23 in JAMA Ophthalmology. Johan Aspberg, M.D., from Lund... (Source: - Pharma News)
Source: - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news

Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34
Mark Cuban, the tech titan, Dallas Mavericks owner, and star of ABC’s Shark Tank, moves through the world like a friendly great white, all teeth and eyes and relentless motion. When we meet on an October morning at his office in the Mavericks’ headquarters, the serial entrepreneur, 64, is wearing a long-sleeved T-shirt advertising his last investment: Mark Cuban Cost Plus Drug Co. I was there to find out why a guy who’s made billions in tech, won an NBA championship, and become perhaps the most popular businessman on reality TV was spending his time and fortune hawking generic anti-fungal medications onli...
Source: TIME: Health - November 17, 2022 Category: Consumer Health News Authors: Charlotte Alter/Dallas Tags: Uncategorized Health Care Magazine uspoliticspolicy Source Type: news

Upstate researcher awarded over $2M to begin first studies of TM cells ’ mechanical memory, improving understanding of its role in glaucoma
Dr Samuel Herberg will study how and why trabecular meshwork cells in the eye react differently to stressors when an individual has glaucoma. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - November 14, 2022 Category: Universities & Medical Training Tags: News Research Source Type: news